SEC Form 4 · accession 0001179110-16-020017
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President · Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 11:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 22, 2016 | S | 1,688 | $9.95 | D | 244,342 | D | |
| Common Stock | holding | — | — | — | 183,596 | I | Craig Wheeler Revocable Trust | |
| Common Stock | holding | — | — | — | 150,000 | I | Craig A. Wheeler 2014 Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
- F2This transaction was executed in multiple trades at prices ranging from $9.65 to $10.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.